Is Response to Prophylactic Lithium a Familial Trait?
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Selecting a drug according to the treatment response in a relative has been widely accepted advice in the management of mood disorders. However, this recommendation has not been adequately substantiated in the literature. We tested the hypothesis that response to long-term lithium treatment is a familial trait. METHOD: We compared response to long-term lithium treatment in bipolar relatives of bipolar lithium responders and bipolar controls. Twenty-four relatives with bipolar disorder (as determined using the Schedule for Affective Disorders and Schizophrenia-Lifetime version [SADS-L] and Research Diagnostic Criteria [RDC]) were identified in families of 106 patients with lithium-responsive bipolar disorder. A consecutive series of 40 lithium-treated patients in a bipolar clinic (meeting RDC and DSM-IV criteria for bipolar disorder) served as a comparison group. Lithium response was evaluated on a rating scale reflecting the quality and quantity of available data. RESULTS: The prevalence of unequivocal response among the relatives was 67%, as compared with the response rate of 35% in the comparison group (chi2 = 6.04, df = 1, p = .014). CONCLUSION: This highly significant difference in response between relatives and the control group supports the view that the response to lithium prophylaxis clusters in families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a study showing that patients who have a lithium‐responsive relative have a 67% likelihood of also being lithium responsive, versus 35% of those without a responsive relative.417”
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Kaplan and Sadock's synopsis of psychiatry
Sadock, B. J., & Sadock, V. A. (1998) · Cited by 450
Relationship Between the Effectiveness of Lithium Therapy and Family History
MENDLEWICZ, J., FIEVE, R. R., & STALLONE, F. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.9.1011 · Cited by 166
DIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTS
Pare, C. M. B., Rees, L., & Sainsbury, M. J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91019-x · Cited by 165
Does Lithium Treatment Still Work?: Evidence of Stable Responses Over Three Decades
Baldessarini, R. J., & Tondo, L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.187 · Cited by 164
Lithium response and genetics of affective disorders
Grof, P., Alda, M., Gror, E., Zvolsky, P., & Walsh, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90066-3 · Cited by 161
Self-citationFamilial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder
Turecki, G., Grof, P., Cavazzoni, P. A., Duffy, A. C., Grof, E., Ahrens, B., Berghöfer, A., Müller-Oerlinghausen, B., Dvorakova, M. C., Libigerová, E., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000447 · Cited by 127
Self-citationPharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116
Cited by
Items 301–400 of 443
Suga, Y., Yoshimoto, K., Numata, S., Shimodera, S., Takamura, S., Kamimura, N., Sawada, K., Kazui, H., Ohmori, T., & Morinobu, S. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12083 · Cited by 4
Camarena, B., Sanabrais‐Jiménez, M. A., Sotelo-Ramírez, C. E., Pavón, J. J., Morales-Cedillo, I. P., Ortega‐Ortíz, H., & Palars, C. B. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00771-0 · Cited by 3
Bodenstein, K., Lesage, M., Lavín, P., Schouws, S. N. T. M., Orhan, M., Beunders, A. J. M., Almeida, O. P., Altınbaş, K., Balanzá‐Martínez, V., Barbosa, I. G., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251372190 · Cited by 4
Hidalgo‐Figueroa, M., Delgado-Sequera, A., Pérez‐Ramos, A., Durán-Ruiz, M. C., Romero-López-Alberca, C., Pérez‐Revuelta, J. I., Marquez-Estefenn, I., García-Mompó, C., Moreno, J. M. V., & Berrocoso, E. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01343-x · Cited by 2
“The BD group was further subdivided according to their ALDA score, resulting in 7 BDR patients and 4 BDNR patients.”
Singh, B., Ho, A. M., Coombes, B. J., Romo‐Nava, F., Bond, D. J., Veldić, M., Pendegraft, R. S., Batzler, A. J., Barboza, A. B. C., Gardea‐Resendez, M., et al. (2025) · International Journal of Bipolar Disorders · doi:10.1186/s40345-025-00405-7 · Cited by 3
“We assessed the response to SGA using the Alda Scale modified for non-lithium mood stabilizing treatments (Grof et al. 2002).”
Miola, A., Fornaro, M., Stefano, V. D., Pullano, I., Monaco, F. L., & Steardo, L. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121152 · Cited by 3
Yeloğlu, Ç. H., Hocaoğlu, Ç., & Bahçeci, B. (2021) · Genel Tıp Dergisi · doi:10.54005/geneltip.996374 · Cited by 2
Elevated choline in dorsolateral prefrontal cortex of lithium responders with bipolar I disorder
Mahal, P., Deep, R., Kumaran, S. S., & Khandelwal, S. K. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103318 · Cited by 2
Lithiumtherapie zur Behandlung affektiver Störungen im höheren Lebensalter
Christl, J., & Supprian, T. (2024) · Der Nervenarzt · doi:10.1007/s00115-023-01601-5 · Cited by 2
Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility
Skvarc, D., Truong, T. T. T., Lundin, R. M., Barnes, R., Wilkes, F., & Singh, A. (2024) · Future Pharmacology · doi:10.3390/futurepharmacol4030032 · Cited by 2
“Many such responses are familial; Angst (1961) [27] first identified strong familial responses to antidepressant medications, later corroborated for lithium in bipolar disorder treatment [28] and antipsychotic response in schizophrenia [29,30].”
The Potential of Using Screening Tools for Bipolar Disorder to Predict Lithium Response
Janiri, D., Pinto, M., Montanari, S., Marzo, E. M., Sfratta, G., Donofrio, G., Koukopoulos, A. E., Camardese, G., Simonetti, A., Moccia, L., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18020269 · Cited by 2
“The most widely adopted and validated method to assess lithium response is the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder, commonly referred to as the Alda Scale, named after its creator, Martin Alda [3].”
Pharmacogenetics of Lithium Response
Cruceanu, C., de Lara, C. L., Alda, M., & Turecki, G. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080601-09 · Cited by 3
Self-citationDuffy, A. C. (2009) · Future Neurology · doi:10.2217/fnl.10.3 · Cited by 2
Self-citationPerlis, R. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00044-5 · Cited by 2
Multimodal modeling for personalized psychiatry
Clark, S. R., Cearns, M., Schubert, K. O., & Baune, B. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00043-2 · Cited by 2
Cansız, A., & İnce, B. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.104971 · Cited by 2
Response to lithium treatment in bipolar disorder as a pharmacogenetic phenotype
Mamdani, F., Groisman, I. J., Alda, M., & Turecki, G. (2004) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629419 · Cited by 2
Self-citationGenomics of Lithium Action and Response
Pickard, B. S. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17305 · Cited by 2
“ium response at the level of the patient is most often achieved using the ‘Alda’ rating scale based on case notes and prescription history [17].”
BackgroundMethodAmare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., Heilbronner, U., Degenhardt, F., Ayele, F. T., Hsu, Y., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/449363 · Cited by 2
Self-citationFerensztajn‐Rochowiak, E., Dmitrzak‐Węglarz, M., Szczepankiewicz, A., Skibińska, M., Kliwicki, S., Permoda-Pachuta, A., Suwalska, A., Czerski, P. M., Pawlak, J., & Hauser, J. (2022) · Psychiatria Polska · doi:10.12740/pp/140889 · Cited by 1
Tortorella, A. A. V., Scopetta, F., Cinesi, G., Baldini, I., Russo, A. G., Amantini, K., Giorgi, F. D., & Menculini, G. (2025) · Brain Sciences · doi:10.3390/brainsci15050490 · Cited by 1
“The Alda Scale is considered to be a valid measure, with interrater reliability of 0.54–0.75 in assessing long-term response to treatments [37,38].”
InfluentialBourdon, C., Courtin, C., Bellivier, F., Scott, J. L., Étain, B., & Cynthia Marie-claire, A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120177 · Cited by 1
Piras, C., Pisanu, C., Spada, M., Meloni, A., Congiu, D., Palmas, V., Severino, G., Ardau, R., Chillotti, C., Contu, M., et al. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf071 · Cited by 2
“3 The more stringent phenotypic definition of lithium response might have increased the sensitivity threshold, r educing the likelihood of spurious findings (type 1 e rror).”
Ho, A. M., Coombes, B. J., Batzler, A. J., Pazdernik, V., Pendegraft, R., Skime, M. K., Bendjemaa, N., Carpiniello, B., Contu, M., Dalkner, N., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03478-7 · Cited by 2
“AMS treatment response was measured using the Alda scale, which has been validated and used by ConLiGen to retrospectively evaluate lithium treatment response in BD patients [9, 10, 14].”
Self-citationPalmas, V., Gama, L. C. D. M., Guima, S. E. S., Sanna, G., Pisanu, C., Piras, C., Spada, M., Meloni, A., Congiu, D., Severino, G., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1839847 · Cited by 1
“…to treatment was evaluated using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder (Alda scale) (Grof et al., 2002), which provides a validated quantitative measure of clinical improvement during mood stabilizer treatment, with total scores…”
Indications curative et préventive dans le trouble bipolaire
Pitchot, W. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.02.008 · Cited by 1
“[8] Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al.”
BackgroundDeiana, V., Chillotti, C., Manchia, M., Pinna, M., Ardau, R., Zompo, M. D., & Severino, G. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318221e7ef · Cited by 1
Biomarkers for Psychosis: the Molecular Genetics of Psychosis
Corvin, A. P., & Harold, D. H. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0041-6 · Cited by 3
“This area remains one of substantial interest as there is evidence of a genetic contribution to the variability in treatment response of current treatments including clozapine [55] and lithium [56].”
BackgroundGenetic studies of bipolar disorder in patients selected by their treatment response
Ortiz‐Domínguez, A., & Alda, M. (2008) · Salud Mental · Cited by 2
Self-citationPharmacoepidemiology of Bipolar Disorder: A Review
Dimellis, D., & Konstantinos, N. (2015) · Cited by 2
Actualización en el uso y el manejo del litio en neuropsiquiatría
Corrales, A., Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Mato, A. M. L., Marengo, E., Abraham, E., Maresca, T., Bagnati, P. R. A. D. N., et al. (2024) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i162.504 · Cited by 2
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.006 · Cited by 1
Modulation of neuronal excitability and plasticity by BHLHE41 conveys lithium non-responsiveness
Stephan, M., Papiol, S., Zhang, M., Song, J., Frommeyer, S. M., Haupt, H., Jensen, N., Kannaiyan, N. R., Gupta, R., Schuler, P., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03822-x · Cited by 1
A physical perspective on lithium therapy
Kamp, D. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.11.002 · Cited by 5
Steardo, L., Fornaro, M., D’Angelo, M., Stefano, V. D., Monaco, F., Scuderi, C., Steardo, L., & Valenza, M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111337 · Cited by 2
Thelwall, P. E., & Cousins, D. A. (2025) · Psychoradiology · doi:10.1093/psyrad/kkaf017 · Cited by 1
“The imaging data, obtained within a month of dose stabilization, will be analysed with respect to response to treatment as determined using the Alda scale (Grof et al. , 2002 ) applied after 1 year of treatment.”
Management of major depressive disorder in primary care.
Dantz, B. (2008) · PubMed · Cited by 1
Lityuma Tedavi Yanıtının Klinik, Biyolojik ve Genetik Yordayıcıları
Bozkurt, H. T., Erbasan, V., Eğilmez, Ü., Şen, B., Aydın, M., & Altınbaş, K. (2018) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.347570 · Cited by 2
Pharmacogenomics of bipolar disorder
Pisanu, C., Squassina, A., Alda, M., & Severino, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00032-8 · Cited by 2
Self-citationCoryell, W. H., & Clayton, P. J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_4 · Cited by 1
Lithium in Psychiatric Indications
Schefft, C., Volkmann, C., & Köhler, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_447 · Cited by 1
New Hope for Pharmacogenetic Testing
Nürnberger, J. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040536 · Cited by 1
Biological mechanisms of environmental stressors in psychiatry : the role of the immune system
Guloksuz, I. S. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151202ig · Cited by 1
REVIEW THE GENETICS OF BIPOLAR DISORDER
Barnett, J. H., & Smoller, J. W. (2009) · Cited by 2
Niemsiri, V., Rosenthal, S. B., Nievergelt, C. M., Maihofer, A. X., Marchetto, M. C., Santos, R., Shekhtman, T., Alliey‐Rodriguez, N., Anand, A., Balaraman, Y., et al. (2022) · medRxiv · doi:10.1101/2022.01.10.21268493 · Cited by 1
Self-citationTravails of Psychiatric Genetics
Balon, R. (2023) · Annals of Clinical Psychiatry · doi:10.12788/acp.0103 · Cited by 1
García-Ortiz, I., Cabrero, R. S., Madridejos-Palomares, E., Martínez-Jiménez, M., Sousa, R. A. B., Carpio-Lopez, I., Sánchez-Alonso, S., López, S. B., Mata-Iturralde, L., García, R. Á., et al. (2026) · medRxiv · doi:10.64898/2026.04.14.26350865 · Cited by 2
The promise of biomarkers and response prediction
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.028
Pharmacogenetics and mood disorders
Laje, G., & McMahon, F. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.029
Prophylactic treatment in bipolar disorder
Eroğlu, M. Z., Özpoyraz, N., & Tamam, L. (2013) · Journal of Mood Disorders · doi:10.5455/jmood.20131216050528
Phenotypic dissection of mood disorder
Forty, L. (2009) · ORCA Online Research @Cardiff (Cardiff University)
Treating bipolar disorder in the early stages of illness
Garland, E., & Duffy, A. C. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.008
Self-citationPractical Pharmacological Maintenance Treatment of Bipolar Disorder
Swann, A. C. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch24
Issues and Clues in the Pharmacological Treatment of Mood Disorders
Jollant, F., Ionita, A., & Courtet, P. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch6
The Use of Family History in Selecting Long-Term Treatment for Patients with Bipolar Disorder
Duffy, A. C. (2003) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.8.7.1.24964
Self-citationA 22-year-old Woman With Excessive Worry, Irritability, Insomnia
Goldberg, J. F. (2004) · Psychiatric Annals · doi:10.3928/0048-5713-20040901-05
Measurement of the Cerebellar Vermis in Bipolar Disorder and the Effect of Lithium Treatment
Mahnke, D. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26850
Aas, M., Blokland, G. A. M., Chawner, S. J. R. A., Choi, S. W., Estrada, J., Forsingdal, A., Friedrich, M. U., Ganesham, S., Hall, L. S., Haslinger, D., et al. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000112
“In addition, response to lithium is a longitudinally stable and familial characteristic (Grof et al., 2002; Berghofer et al., 2008).”
BackgroundGenetic Influences on Response to Mood Stabilizers in Bipolar
RYBAKOWSKI, J. K. (2013)
Pharmacogenetics of Mood Stabilizers
RYBAKOWSKI, J. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-27040-1_6
“In 2002, the Canadian researchers introduced a scale allowing quantitative retrospective assessment of the quality of prophylactic lithium response [ 14 ].”
BackgroundLithium Response Variability (Pharmacogenomics Studies)
Dayer, A. G., Perroud, N. A., & Aubry, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45923-3_8
Lithium in Older Age Bipolar Disorder
Rej, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_7
Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Heilbronner, U., Degenhardt, F., Ayele, F. T., Hsu, Y., Shekhtman, T., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/209270
Self-citationMontlahuc, C., Curis, E., Laroche, D. G., Bagoe, G., Étain, B., Bellivier, F., & Chevret, S. (2018) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2018.03.091
Farmacogenética do lítio: marcadores de refratariedade em pacientes com transtorno bipolar
de Nicola, B. V. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-23052019-104412 · Cited by 2
Studying cellular functions in bipolar disorder: Are there specific predictors of lithium response?Preprint
Paul, P., Iyer, S., Nadella, R. K., Nayak, R., Chellappa, A. S., Ambardar, S., Sud, R., Sukumaran, S. K., Purushottam, M., Jain, S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/753574
“All patients were assessed for clinical lithium response using the Alda Scale and NIMH Retrospective Life chart method [4,8].”
BackgroundMethodMichelon, L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-25102019-131555 · Cited by 1
The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations
Heilbronner, U. (2019) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-4-1-51-52
“As response phenotype for lithium treatment, ConLiGen has been using an 11-point rating scale defined by Martin Alda and colleagues (Grof et al., 2002).”
MethodResultGenetic Predictors of Lithium Response
Heilbronner, U. (2019) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-4-1-26-27
“As previous studies have also found evidence that lithium response is a familial trait (Grof et al., 2002), this implicates that there may be genetic factors mediating treatment response.”
BackgroundMethodLithium pharmacogenetics. Two decades of studies
Sobczak, M. D., & Pawlak, J. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.05.002
Lithium stabilization and misunderstandings: Toward understanding why lithium is underutilized
Grof, P., & Duffy, A. C. (2020) · Bipolar Disorders · doi:10.1111/bdi.13000
Self-citationIs there a biosignature for lithium response in bipolar disorder? Evidence and implications
Fornaro, M., Anastasia, A., Fusco, A., & Carvalho, A. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00034-x
Lithium in Psychiatric Indications
Schefft, C., Volkmann, C., & Köhler, S. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_447-1
Pharmacogenomics of bipolar disorder
Pisanu, C., & Squassina, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00012-0
Sparks, G. M., & Axelson, D. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch11
Current Awareness in Human Psychopharmacology
(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.459
Lee, Y., Lee, D., Jung, H., Cho, Y., Baek, J. H., & Hong, K. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1403711/v1
Pharmacogenomics and mood stabilizers: efficacy and adverse drug reactions
Pisanu, C., & Squassina, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819602-1.00012-7
Neurobiological Foundations of Mood Disorders
Manchia, M., & Schatzberg, A. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_83-1
Stacey, D., Suppiah, V., Benyamin, B., Lee, H.-S., & Hyppönen, E. (2024) · medRxiv · doi:10.1101/2024.03.27.24304993 · Cited by 3
Prioritizing the Components of Any Decision-Making Model
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.012
Cohort Profile: The St. Göran Bipolar ProjectPreprint
Pålsson, E., Jönsson, L., Klahn, A. L., Kardell, M., Göteson, A., Abé, C., Aspholmer, A., Liberg, B., Pelanis, A., Sparding, T., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4436841/v1
Lee, D. E., & Baek, J. H. (2024) · Precision and Future Medicine · doi:10.23838/pfm.2024.00058
“The Retrospective Assessment of Response to Lithium Scale (Alda scale) was developed for this purpose by Martin Alda and colleagues [11,12].”
BackgroundMethodInfluentialMishra, R., Quraishi, R., Deep, R., & Jain, R. (2024) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_119_24
Chapter 12. Assessment, Prognosis, and Treatment of Subthreshold Mood Symptoms
Hafeman, D., & Spada, M. L. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg12
Chapter 7. Evidence-Based Psychotherapies for Pediatric Depressive Disorders
Santamarina, P., & West, M. P. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg07
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.bm03
Carlson, G. A. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg03
Chapter 10. Pharmacotherapy for Pediatric Bipolar Disorders
Patino, L. R., & DelBello, M. P. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg10
Chapter 6. Neuroscience of Childhood-Onset Bipolar Disorder: Translation of Science to Service
May, A., Weinstein, S. M., Carbray, J. A., & Pavuluri, M. N. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg06
Chapter 1. Principles of Assessment of Mood Disorders in Childhood
Singh, M. K. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg01
Chapter 2. DSM-5 Diagnosis of Mood Disorders in Children and Adolescents
Meter, A. V. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg02
Appendix A. Resources and Readings
Singh, M. K. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.bm01
Chapter 16. Preventative and Emerging Pharmacological and Nonpharmacological Treatments
Dickstein, D. P., & Croarkin, P. E. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg16
Appendix B. Quick Reference Facts for the Treatment of Pediatric Mood Disorders
Singh, M. K. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.bm02
Chapter 9. Pharmacotherapy for Pediatric Depression
Kim, G.-M., Gandhi, R., & Cullen, K. R. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg09
Chapter 14. Management of Common Co-occurring Conditions in Pediatric Mood Disorders
Larios, D. A., & Galanter, C. A. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg14
Metadata
- Authors
- Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M.
- Affiliations
- University of Ottawa (CA)
- Dalhousie University (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-10-15
- Volume
- 63
- Issue
- 10
- Pages
- 942-947
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2136422355
- Semantic Scholar
- 5c8d39caedae6c6c21cb238faa737643cc7f8b07
- Cited by
- 438
- References
- 23
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 28 · 2023: 17 · 2022: 30 · 2021: 19 · 2020: 29 · 2019: 43 · 2018: 30 · 2017: 23 · 2016: 22 · 2015: 16 · 2014: 23 · 2013: 22 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium response, bipolar disorder, family transmission, genetic susceptibility, long-term lithium therapy, treatment response
- MeSH terms
- Adult, Bipolar Disorder, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Family, Female, Humans, Lithium, Male, Middle Aged, Pharmacogenetics, Psychiatric Status Rating Scales, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.